AACR Project GENIE 19.0-Public Release

LATEST News

• The AACR Project GENIE Data Model (GDM), developed by the AACR Project GENIE consortium, is an open-source, pan-cancer framework that standardizes longitudinal clinico-genomic data from diagnosis through long-term outcomes.
• AACR Project GENIE v19.0-public is now available (271,837 samples / 227,696 patients) with newly added cfDNA samples.
• All Phase 1 Biopharma Collaborative datasets (NSCLC, CRC, PANC, Prostate, Breast, and Bladder are now publicly available. 
• On November 6, AACR Project GENIE celebrated 10 years of Powering Precision Cancer Medicine  and Collaborating to Advance Cancer Precision Medicine Globally.
• At the Molecular Targets Meeting in Boston, Massachusetts, sessions highlighted the diverse applications of AACR Project GENIE data, including leveraging clinico-genomic information for research (Ken Kehl, DFCI), examining off-label targeted therapy utilization within GENIE BPC datasets (Jeremy Warner, Brown), and identifying novel drug targets through GENIE data analysis (Phillip Beer, Step Pharma).

• AACR Project GENIE was prominently featured at the AACR Annual Meeting 2026.

• The latest GENIE publication: Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer – PMC, JCO Precision Oncology, Volume 9, April 2025.

• Watch the Believe in Progress episode: AACR Project GENIE: A Conversation with Shawn M. Sweeney, PhD, and Philippe L. Bedard, MD. 

• New public data portal available from Sage Bionetworks. 

• Learn more about AACR Project GENIE data included as part of sotorasib regulatory approval. 

• Visit the AACR Blog, Cancer Research Catalyst, for more information about AACR Project GENIE®.